The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Starch–poly(ε‐caprolactone) and starch–poly(lactic acid) fibre‐mesh scaffolds for bone tissue engineering applications: structure, mechanical properties and degradation behaviour
Open accessAbstract
In scaffold-based tissue engineering strategies, the successful regeneration of tissues from matrix-producing connective tissue cells or anchorage-dependent cells (e.g. osteoblasts) relies on the use of a suitable scaffold. This study describes the development and characterization of SPCL (starch with epsilon-polycaprolactone, 30:70%) and SPLA [starch with poly(lactic acid), 30:70%] fibre-meshes, aimed at application in bone tissue-engineering strategies. Scaffolds based on SPCL and SPLA were prepared from fibres obtained by melt-spinning by a fibre-bonding process. The porosity of the scaffolds was characterized by microcomputerized tomography (microCT) and scanning electron microscopy (SEM). Scaffold degradation behaviour was assessed in solutions containing hydrolytic enzymes (alpha-amylase and lipase) in physiological concentrations, in order to simulate in vivo conditions. Mechanical properties were also evaluated in compression tests. The results show that these scaffolds exhibit adequate porosity and mechanical properties to support cell adhesion and proliferation and also tissue ingrowth upon implantation of the construct. The results of the degradation studies showed that these starch-based scaffolds are susceptible to enzymatic degradation, as detected by increased weight loss (within 2 weeks, weight loss in the SPCL samples reached 20%). With increasing degradation time, the diameter of the SPCL and SPLA fibres decreases significantly, increasing the porosity and consequently the available space for cells and tissue ingrowth during implantation time. These results, in combination with previous cell culture studies showing the ability of these scaffolds to induce cell adhesion and proliferation, clearly demonstrate the potential of these scaffolds to be used in tissue engineering strategies to regenerate bone tissue defects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Synthetic biodegradable polymers as orthopedic devices
Middleton, J. C., & Tipton, A. J. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00101-0 · Cited by 2,741
Xiao, Y., Qian, H., Young, W. G., & Bartold, P. M. (2003) · Tissue Engineering · doi:10.1089/10763270360728071 · Cited by 123
Research works printed but not linked: 41
- Atala, 2007, Engineering tissues, organs and cells, J Tissue Eng Regen Med, 1, 83, 10.1002/term.18 · DOI · Paper page
- Azevedo, 2003, In vitro assessment of the enzymatic degradation of several starch based biomaterials, Biomacromolecules, 4, 1703, 10.1021/bm0300397 · DOI · Paper page
- Azevedo, 2005, Biodegradable Systems in Tissue Engineering and Regenerative Medicine, 177
- Catiker, 2000, Degradation of PLA, PLGA homo‐ and copolymers in the presence of serum albumin: a spectroscopic investigation, Polymer Int, 49, 728, 10.1002/1097-0126(200007)49:7<728::AID-PI443>3.0.CO;2-3 · doi:10.1002/1097-0126(200007)49:7<728::aid-pi443>3.0.co;2-3
- Chapekar, 2000, Tissue engineering: challenges and opportunities, J Biomed Mater Res Appl Biomater, 53, 617, 10.1002/1097-4636(2000)53:6<617::AID-JBM1>3.0.CO;2-C · DOI · Paper page
- Chastain, 2006, Adhesion of mesenchymal stem cells to polymer scaffolds occurs via distinct ECM ligands and controls their osteogenic differentiation, J Biomed Mater Res A, 78A, 73, 10.1002/jbm.a.30686 · DOI · Paper page
- Chawla, 2002, Biodegradable poly(ε‐caprolactone) nanoparticles for tumor‐targeted delivery of tamoxifen, Int J Pharmaceut, 249, 127, 10.1016/S0378-5173(02)00483-0 · DOI · Paper page
- Correlo, 2007, Biomedical Polymers, 197, 10.1533/9781845693640.197 · doi:10.1533/9781845693640.197
- De Jong, 2005, Tissue response to partially in vitro predegraded poly‐L‐lactide implants, Biomaterials, 26, 1781, 10.1016/j.biomaterials.2004.06.026 · DOI
- Freed, 1998, Culture of organized cell communities, Adv drug Delivery, 33, 15, 10.1016/S0169-409X(98)00017-9 · DOI · Paper page
- Freed, 1994, Biodegradable polymer scaffolds for tissue engineering, Biotechnology, 12, 689
- Gan, 1997, Enzymatic degradation of poly(ε‐caprolactone) film in phosphate buffer solution containing lipases, Polym Degrad Stabil, 56, 209, 10.1016/S0141-3910(96)00208-X · DOI · Paper page
- Gan, 1999, Enzymatic degradation of poly(ε‐caprolactone)/poly(DL‐lactide) blends in phosphate buffer solution, Polymer, 40, 2859, 10.1016/S0032-3861(98)00549-7 · DOI · Paper page
- Gomes, 2006, In vitro localization of bone growth factors in constructs of biodegradable scaffolds seeded with marrow stromal cells and cultured in a flow perfusion bioreactor, Tissue Eng, 12, 177, 10.1089/ten.2006.12.177 · DOI
- Gomes, 2006, Influence of the porosity of starch‐based fibre‐mesh scaffolds on the proliferation and osteogenic differentiation of bone marrow stromal cells cultured in a flow perfusion bioreactor, Tissue Eng, 12, 801, 10.1089/ten.2006.12.801 · DOI · Paper page
- Gomes, 2003, Effect of flow perfusion on the osteogenic differentiation of bone marrow stromal cells cultured on starch‐based three‐dimensional scaffolds, J Biomed Mater Res A, 67A, 87, 10.1002/jbm.a.10075 · DOI · Paper page
- He, 2003, Enzyme‐catalyzed polymerization and degradation of copolymers prepared from ε‐caprolactone and poly(ethylene glycol), Polymer, 44, 5145, 10.1016/S0032-3861(03)00562-7 · DOI · Paper page
- Hutmacher, 2000, Scaffolds in tissue engineering bone and cartilage, Biomaterials, 21, 2529, 10.1016/S0142-9612(00)00121-6 · DOI · Paper page
- Hutmacher, 2007, State of the art and future directions of scaffold‐based bone engineering from a biomaterials perspective, J Tissue Eng Regen Med, 1, 245, 10.1002/term.24 · DOI · Paper page
- Junge, 1989, Evaluation of a new assay for pancreatic amylase—performance characteristics and estimation of reference intervals, Clin Biochem, 22, 109, 10.1016/S0009-9120(89)80007-4 · DOI
- Kim, 1998, Development of biocompatible synthetic extracellular matrices for tissue engineering, Trends Biotechnol, 16, 224, 10.1016/S0167-7799(98)01191-3 · DOI · Paper page
- Langer, 1999, Selected advances in drug delivery and tissue engineering, J Control Release, 62, 7, 10.1016/S0168-3659(99)00057-7 · DOI
- Li, 1999, Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids, J Biomed Mater Res, 48, 342, 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7 · DOI · Paper page
- Liu, 2000, Selective enzymatic degradations of poly(L‐lactide) and poly(ε‐caprolactone) blend films, Biomacromolecules, 1, 350, 10.1021/bm000046k · DOI · Paper page
- Lu, 1996, The importance of new processing techniques in tissue engineering, MRS Bull Mater Res Soc, 21, 28, 10.1557/S088376940003181X · DOI · Paper page
- Maquet, 1997, Design of macroporous biodegradable polymer scaffolds for cell transplantation, Porous Mater Tissue Eng, 250, 15
- Mendes, 2003, Evaluation of two biodegradable polymeric systems as substrates for bone tissue engineering, Tissue Eng, 9, S91, 10.1089/10763270360697003 · DOI
- Nam, 2000, A novel fabrication method of macroporous biodegradable polymer scaffolds using gas foaming salt as a porogen additive, J Biomed Mater Res, 53, 1, 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R · DOI · Paper page
- Oliveira, 2007, A cartilage tissue engineering approach combining starch–polycaprolactone fibre‐mesh scaffolds with bovine articular chondrocytes, J Mater Sci Mater Med, 18, 295, 10.1007/s10856-006-0692-7 · DOI
- Pei, 2002, Bioreactors mediate the effectiveness of tissue engineering scaffolds, FASEB J, 16, 1691, 10.1096/fj.02-0083fje · DOI · Paper page
- Pena, 2006, Long‐term degradation of poly(ε‐caprolactone) films in biologically related fluids, Polym Degrad Stabil, 91, 1424, 10.1016/j.polymdegradstab.2005.10.016 · DOI · Paper page
- Santos, 2007, Response of micro‐ and macrovascular endothelial cells to starch‐based fibre‐meshes for bone tissue engineering, Biomaterials, 28, 240, 10.1016/j.biomaterials.2006.08.006 · DOI
- Thompson, 1995, Biodegradable polymer scaffolds to regenerate organs, Adv Polym Sci, 122, 247
- Thompson, 1997, Polymer Scaffold Processing. Principles of Tissue Engineering, 263
- Thomson, 1995, Fabrication of biodegradable polymer scaffolds to engineer trabecular bone, J Biomater Sci Polym Ed, 7, 23, 10.1163/156856295X00805 · DOI · Paper page
- Tietz, 1993, Lipase in serum—the elusive enzyme—an overview, Clin Chem, 39, 746, 10.1093/clinchem/39.5.746 · DOI · Paper page
- Tsuji, 2005, Poly(lactide) stereocomplexes: formation, structure, properties, degradation, and applications, Macromol Biosci, 5, 569, 10.1002/mabi.200500062 · DOI · Paper page
- Tsuji, 2006, Enzymatic degradation of biodegradable polyester composites of poly(L‐lactic acid) and poly(ε‐caprolactone), Macromol Mater Eng, 291, 1245, 10.1002/mame.200600276 · DOI
- Vacanti, 1999, An overview of tissue engineered bone, Clin Orthop, 367, S375, 10.1097/00003086-199910001-00036 · DOI
- Williams, 2005, Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering, Biomaterials, 26, 4817, 10.1016/j.biomaterials.2004.11.057 · DOI · Paper page
- Zhang, 1999, Poly(α‐hydroxyl acids) hydroxyapatite porous composites for bone‐tissue engineering. I. Preparation and morphology, J Biomed Mater Res, 44, 446, 10.1002/(SICI)1097-4636(19990315)44:4<446::AID-JBM11>3.0.CO;2-F · DOI · Paper page
Cited by
A review of trends and limitations in hydrogel-rapid prototyping for tissue engineering
Billiet, T., Vandenhaute, M., Schelfhout, J., Van Vlierberghe, S., & Dubruel, P. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.050 · Cited by 1,284
Sobral, J. M., Caridade, S. G., Sousa, R. A., Mano, J. F., & Reis, R. L. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.11.003 · Cited by 561
Self-citationKhorshidi, S., Solouk, A., Mirzadeh, H., Mazinani, S., Lagaron, J. M., Sharifi, S., & Ramakrishna, S. (2016) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1978 · Cited by 546
Fiber-based tissue engineering: progress, challenges, and opportunities
Tamayol, A., Akbari, M., Annabi, N., Paul, A., Khademhosseini, A., & Juncker, D. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.11.007 · Cited by 458
Santos, M. I., & Reis, R. L. (2010) · Macromolecular Bioscience · doi:10.1002/mabi.200900107 · Cited by 443
Self-citationElectrospun Polycaprolactone (PCL) Degradation: An In Vitro and In Vivo Study
Dias, J. R., Sousa, A., Augusto, A., Bártolo, P. J., & Granja, P. L. (2022) · Polymers · doi:10.3390/polym14163397 · Cited by 293
Polycaprolactone/starch composite: Fabrication, structure, properties, and applications
Ali Akbari Ghavimi, S., Ebrahimzadeh, M. H., Solati-Hashjin, M., & Abu Osman, N. A. (2015) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35371 · Cited by 151
Asl, M. A., Karbasi, S., Beigi-Boroujeni, S., Zamanlui Benisi, S., & Saeed, M. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.09.078 · Cited by 94
Nano-hydroxyapatite/collagen composite as scaffold material for bone regeneration.
Kavitha Sri, A., Arthi, C., Neya, N. R., & Hikku, G. S. (2023) · Biomedical Materials · doi:10.1088/1748-605x/acc99e · Cited by 57
Metadata
- Authors
- Gomes, M. E., Azevedo, H. S., Moreira, A. R., Ellä, V., Kellomäki, M., & Reis, R. L.
- Venue
- Journal of Tissue Engineering and Regenerative Medicine
- Publisher
- Hindawi Limited
- Published
- 2008-07
- Volume
- 2
- Issue
- 5
- Pages
- 243-252
- ISSN
- 1932-6254 (ISSN-L)
- 1932-7005
- OpenAlex
- W2104427836
- Cited by
- 161
- References
- 2
- FWCI
- 9.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 2618 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.